COYA · Company research
Coya Therapeutics, Inc. Common Stock (COYA): Stock News & Events
Recent company-linked news records available in the database.
RESEARCH CONTEXT
Understand the numbers
Recent company-linked news records available in the database. Use period, currency, units and source fields when interpreting values.
18records availableHealthcare
Stock News & Events data
Database-backed records only
| title | summary | url | source | published at | sentiment | sentiment score | relevance score |
|---|---|---|---|---|---|---|---|
| ALS development takes priority as Coya Therapeutics (COYA) delays another trial's planned start. - Stock Titan | ALS development takes priority as Coya Therapeutics (COYA) delays another trial's planned start. Stock Titan | View source ↗ | Stock Titan | Oct 14, 2026 | neutral | 0 | 0.6 |
| A New York panel will discuss Alzheimer's and Parkinson's on Oct. 20 - Stock Titan | A New York panel will discuss Alzheimer's and Parkinson's on Oct. 20 Stock Titan | View source ↗ | Stock Titan | Oct 13, 2026 | neutral | 0 | 0.6 |
| Coya Therapeutics stock reiterated at Buy by H.C. Wainwright on trial enrollment - Investing.com | Coya Therapeutics stock reiterated at Buy by H.C. Wainwright on trial enrollment Investing.com | View source ↗ | Investing.com | Oct 6, 2026 | neutral | 0 | 0.6 |
| Coya Therapeutics, Inc. (COYA) Stock Price, News, Quote & History - Yahoo! Finance Canada | Coya Therapeutics, Inc. (COYA) Stock Price, News, Quote & History Yahoo! Finance Canada | View source ↗ | Yahoo! Finance Canada | Oct 6, 2026 | neutral | 0 | 0.6 |
| Coya Therapeutics, Inc. (COYA) stock price, news, quote and history - Yahoo Finance Singapore | Coya Therapeutics, Inc. (COYA) stock price, news, quote and history Yahoo Finance Singapore | View source ↗ | Yahoo Finance Singapore | Oct 6, 2026 | neutral | 0 | 0.6 |
| An ALS trial hits its enrollment target at Coya Therapeutics (COYA), with results expected in early Q2 2027. - Stock Titan | An ALS trial hits its enrollment target at Coya Therapeutics (COYA), with results expected in early Q2 2027. Stock Titan | View source ↗ | Stock Titan | Oct 5, 2026 | neutral | 0 | 0.6 |
| 120 people joined a potential Lou Gehrig’s disease treatment trial. Data are expected in 2027. - Stock Titan | 120 people joined a potential Lou Gehrig’s disease treatment trial. Data are expected in 2027. Stock Titan | View source ↗ | Stock Titan | Oct 5, 2026 | neutral | 0 | 0.6 |
| Coya Therapeutics (COYA) Ticks Higher: Shares Gain 1.48% to $4.80 - Stop Loss Guidance - https://www.siam.in/ | Coya Therapeutics (COYA) Ticks Higher: Shares Gain 1.48% to $4.80 - Stop Loss Guidance https://www.siam.in/ | View source ↗ | https://www.siam.in/ | Oct 2, 2026 | neutral | 0 | 0.6 |
| Coya Therapeutics Advances COYA 302 ALS Phase 2/3 Trial - The Globe and Mail | Coya Therapeutics Advances COYA 302 ALS Phase 2/3 Trial The Globe and Mail | View source ↗ | The Globe and Mail | Sep 16, 2026 | neutral | 0 | 0.6 |
| Wall Street Analysts Are Bullish on Top Healthcare Picks - The Globe and Mail | Wall Street Analysts Are Bullish on Top Healthcare Picks The Globe and Mail | View source ↗ | The Globe and Mail | Aug 25, 2026 | neutral | 0 | 0.6 |
| Coya Therapeutics Advances Phase 2 ALSTARS ALS Trial Toward 2026 Enrollment Finish - Streetwise Reports | Coya Therapeutics Advances Phase 2 ALSTARS ALS Trial Toward 2026 Enrollment Finish Streetwise Reports | View source ↗ | Streetwise Reports | Aug 25, 2026 | neutral | 0 | 0.6 |
| Coya Therapeutics Reports Second Quarter 2026 Financial Results and Provides a Corporate Update - BioSpace | Coya Therapeutics Reports Second Quarter 2026 Financial Results and Provides a Corporate Update BioSpace | View source ↗ | BioSpace | Aug 11, 2026 | neutral | 0 | 0.6 |
| Coya Therapeutics Reports Q2 Net Loss of $6.6 Million - Quiver Quantitative | Coya Therapeutics Reports Q2 Net Loss of $6.6 Million Quiver Quantitative | View source ↗ | Quiver Quantitative | Aug 11, 2026 | neutral | 0 | 0.6 |
| Discipline and Rules-Based Execution in COYA Response - Stock Traders Daily | Discipline and Rules-Based Execution in COYA Response Stock Traders Daily | View source ↗ | Stock Traders Daily | Jul 22, 2026 | neutral | 0 | 0.6 |
| Is Coya Therapeutics, Inc. (COYA) Stock Outpacing Its Medical Peers This Year? - Yahoo Finance | Is Coya Therapeutics, Inc. (COYA) Stock Outpacing Its Medical Peers This Year? Yahoo Finance | View source ↗ | Yahoo Finance | Jun 30, 2026 | neutral | 0 | 0.6 |
| COYA Forecast — Price Target — Prediction for 2027 - TradingView | COYA Forecast — Price Target — Prediction for 2027 TradingView | View source ↗ | TradingView | Jun 25, 2026 | neutral | 0 | 0.6 |
| Houston biotech co. raises $11M to advance ALS drug development - InnovationMap | Houston biotech co. raises $11M to advance ALS drug development InnovationMap | View source ↗ | InnovationMap | Feb 10, 2026 | neutral | 0 | 0.6 |
| Coya Therapeutics Announces $11.1 Million Private Placement - Business Wire | Coya Therapeutics Announces $11.1 Million Private Placement Business Wire | View source ↗ | Business Wire | Jan 30, 2026 | neutral | 0 | 0.6 |
Informational research only, not financial advice. Forecasts are uncertain and can be wrong.